Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy

References

• Carelli V, La Morgia C, Iommarini L, Carroccia R, Mattiazzi M, Sangiorgi S, Farne S, Maresca A, Foscarini B, Lanzi L, et al. Mitochondrial optic neuropathies: how two genomes may kill the same cell type? Biosci Rep. 2007;27:173–84. doi:10.1007/s10540-007-9045-0.
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46:145–58. doi:10.1136/jmg.2007.054270.
   PubMed Web of Science ®Google Scholar
• Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, Klopstock T, Griffiths PG, Hudson G, Chinnery PF, Yu-Wai-Man P. Quality of life in patients with leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50:3112–15. doi:10.1167/iovs.08-3166.
   PubMed Web of Science ®Google Scholar
• Cwerman-Thibault H, Augustin S, Lechauve C, Ayache J, Ellouze S, Sahel JA, Corral-Debrinski M. Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss. Mol Ther Methods Clin Dev. 2015;2:15003. doi:10.1038/mtm.2015.3.
   PubMed Web of Science ®Google Scholar
• Gueven N. Idebenone for Leber’s hereditary optic neuropathy. Drugs Today (Barc). 2016;52:173–81. doi:10.1358/dot.2016.52.3.2463564.
   PubMed Web of Science ®Google Scholar
• Haefeli RH, Erb M, Gemperli AC, Robay D, Courdier Fruh I, Anklin C, Dallmann R, Gueven N. NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS One. 2011;6:e17963. doi:10.1371/journal.pone.0017963.
   PubMed Web of Science ®Google Scholar
• Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J Neuroophthalmol. 2000;20:166–70. doi:10.1097/00041327-200020030-00006.
   PubMed Web of Science ®Google Scholar
• Barnils N, Mesa E, Munoz S, Ferrer-Artola A, Arruga J. [Response to idebenone and multivitamin therapy in Leber’s hereditary optic neuropathy]. Arch Soc Esp Oftalmol. 2007;82:377–80. doi:10.4321/s0365-66912007000600012.
   PubMedGoogle Scholar
• Cheng SW, Ko CH, Yau SK, Mak C, Yuen YF, Lee CY. Novel use of idebenone in Leber’s hereditary optic neuropathy in Hong Kong. Hong Kong Med J. 2014;20:451–54. doi:10.12809/hkmj134085.
   PubMed Web of Science ®Google Scholar
• Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, Atawan A, Chattopadhyay S, Schubert M, Garip A, et al. A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy. Brain. 2011;134:2677–86. doi:10.1093/brain/awr170.
   PubMed Web of Science ®Google Scholar
• Klopstock T, Metz G, Yu-Wai-Man P, Buchner B, Gallenmuller C, Bailie M, Nwali N, Griffiths PG, von Livonius B, Reznicek L, et al. Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy. Brain. 2013;136:e230. doi:10.1093/brain/aws279.
   PubMed Web of Science ®Google Scholar
• Carelli V, La Morgia C, Valentino ML, Rizzo G, Carbonelli M, De Negri AM, Sadun F, Carta A, Guerriero S, Simonelli F, et al. Idebenone treatment in Leber’s hereditary optic neuropathy. Brain. 2011;134:e188. doi:10.1093/brain/awr180.
   PubMed Web of Science ®Google Scholar
• Rudolph G, Dimitriadis K, Buchner B, Heck S, Al-Tamami J, Seidensticker F, Rummey C, Leinonen M, Meier T, Klopstock T. Effects of idebenone on color vision in patients with leber hereditary optic neuropathy. J Neuroophthalmol. 2013;33:30–36. doi:10.1097/WNO.0b013e318272c643.
   PubMed Web of Science ®Google Scholar
• Newman NJ. Treatment of Leber hereditary optic neuropathy. Brain. 2011;134:2447–50. doi:10.1093/brain/awr192.
   PubMed Web of Science ®Google Scholar
• Carelli V, Carbonelli M, de Coo IF, Kawasaki A, Klopstock T, Lagreze WA, La Morgia C, Newman NJ, Orssaud C, Pott JWR, et al. International consensus statement on the clinical and therapeutic management of leber hereditary optic neuropathy. J Neuroophthalmol. 2017;37:371–81. doi:10.1097/WNO.0000000000000570.
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA. Idebenone: a review in leber’s hereditary optic neuropathy. Drugs. 2016;76:805–13. doi:10.1007/s40265-016-0574-3.
   PubMed Web of Science ®Google Scholar
• Newman NJ, Biousse V, Newman SA, Bhatti MT, Hamilton SR, Farris BK, Lesser RL, Turbin RE. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial. Am J Ophthalmol. 2006;141:1061–67. doi:10.1016/j.ajo.2005.12.045.
   PubMed Web of Science ®Google Scholar
• Oguchi Y. Past, present, and future in Leber’s hereditary optic neuropathy. Nihon Ganka Gakkai Zasshi. 2001;105:809–27.
   PubMedGoogle Scholar
• Ran R, Yang S, He H, Ma S, Chen Z, Li B. A retrospective analysis of characteristics of visual field damage in patients with Leber’s hereditary optic neuropathy. Springerplus. 2016;5:843. doi:10.1186/s40064-016-2540-7.
   PubMedGoogle Scholar
• Jarc-Vidmar M, Tajnik M, Brecelj J, Fakin A, Sustar M, Naji M, Stirn-Kranjc B, Glavac D, Hawlina M. Clinical and electrophysiology findings in Slovene patients with Leber hereditary optic neuropathy. Doc Ophthalmol. 2015;130:179–87. doi:10.1007/s10633-015-9489-7.
   PubMed Web of Science ®Google Scholar
• Schaffler K, Hadler D, Stark M. Dose-effect relationship of idebenone in an experimental cerebral deficit model. Pilot study in healthy young volunteers with piracetam as reference drug. Arzneimittelforschung. 1998;48:720–26.
   PubMed Web of Science ®Google Scholar
• Barboni P, Carbonelli M, Savini G, Ramos Cdo V, Carta A, Berezovsky A, Salomao SR, Carelli V, Sadun AA. Natural history of Leber’s hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology. 2010;117:623–27. doi:10.1016/j.ophtha.2009.07.026.
   PubMed Web of Science ®Google Scholar
• Barboni P, Savini G, Feuer WJ, Budenz DL, Carbonelli M, Chicani F, Ramos Cdo V, Salomao SR, Negri AD, Parisi V, et al. Retinal nerve fiber layer thickness variability in Leber hereditary optic neuropathy carriers. Eur J Ophthalmol. 2012;22:985–91. doi:10.5301/ejo.5000154.
   PubMed Web of Science ®Google Scholar
• Moster SJ, Moster ML, Scannell Bryan M, Sergott RC. Retinal ganglion cell and inner plexiform layer loss correlate with visual acuity loss in LHON: a longitudinal, segmentation OCT analysis. Invest Ophthalmol Vis Sci. 2016;57:3872–83. doi:10.1167/iovs.15-17328.
   PubMed Web of Science ®Google Scholar
• Lam BL, Burke SP, Wang MX, Nadayil GA, Rosa PR, Gregori G, Feuer WJ, Cuprill-Nilson S, Vandenbroucke R, Zhang X, et al. Macular retinal sublayer thicknesses in G11778A leber hereditary optic neuropathy. Ophthalmic Surg Lasers Imaging Retina. 2016;47:802–10. doi:10.3928/23258160-20160901-02.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang H, Wei S, Gong Y, Li H, Dai Y, Zhao S, Wang Y, Yan H. Characterization of macular thickness changes in Leber’s hereditary optic neuropathy by optical coherence tomography. BMC Ophthalmol. 2014;14:105. doi:10.1186/1471-2415-14-105.
   PubMed Web of Science ®Google Scholar
• Barboni P, Savini G, Valentino ML, La Morgia C, Bellusci C, De Negri AM, Sadun F, Carta A, Carbonelli M, Sadun AA, et al. Leber’s hereditary optic neuropathy with childhood onset. Invest Ophthalmol Vis Sci. 2006;47:5303–09. doi:10.1167/iovs.06-0520.
   PubMed Web of Science ®Google Scholar
• Ramos Cdo V, Bellusci C, Savini G, Carbonelli M, Berezovsky A, Tamaki C, Cinoto R, Sacai PY, Moraes-Filho MN, Miura HM, et al. Association of optic disc size with development and prognosis of Leber’s hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50:1666–74. doi:10.1167/iovs.08-2695.
   PubMed Web of Science ®Google Scholar